Steven Ryder
CIK 1872868 · Chief Medical Officer · last filed 2026-06-05
Steven Ryder is a Chief Medical Officer who has filed 10 SEC Form 4 insider transactions across 3 companies since 2022. The most recent filing, for MBX, was dated Jun 5, 2026.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
10
$0
Holdings By Company
Recent Filings
10 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-05 | MBX | Grant (A) | — | $0 | EDGAR |
| 2025-06-06 | MBX | Grant (A) | — | $0 | EDGAR |
| 2025-02-19 | RLYB | Grant (A) | — | $0 | EDGAR |
| 2024-09-13 | MBX | Grant (A) | — | $0 | EDGAR |
| 2024-02-16 | RLYB | Grant (A) | — | $0 | EDGAR |
| 2023-09-26 | REATA PHARMACEUTICALS INC (RETA) Delisted | Disp (D) | −10,907 | $0 | EDGAR |
| 2023-06-09 | REATA PHARMACEUTICALS INC (RETA) Delisted | Grant (A) | +2,029 | $189.9K | EDGAR |
| 2023-02-06 | RLYB | Grant (A) | — | $0 | EDGAR |
| 2022-07-12 | REATA PHARMACEUTICALS INC (RETA) Delisted | Grant (A) | +8,878 | $287.3K | EDGAR |
| 2022-02-09 | RLYB | Grant (A) | — | $0 | EDGAR |